Protocol paper: Multi-site, cluster-randomized clinical trial for optimizing functional outcomes of older cancer survivors after chemotherapy.
S Yilmaz, M C Janelsins, M Flannery...
https://pubmed.ncbi.nlm.nih.gov/35292232/Actively Recruiting
Led by University of Rochester · Updated on 2026-01-13
668
Participants Needed
45
Research Sites
17 weeks
Total Duration
Researchers are evaluating the impact of geriatric evaluation and management combined with survivorship health education GEM-S compared to usual care on physical function in older cancer survivors. This phase III trial aims to improve how older adults who have survived cancer manage daily activities, mental well-being, and memory after chemotherapy. The study also seeks to understand how such care affects the quality of life for both cancer survivors and their caregivers. Participants are assigned to one of two groups based on their practice site. One group receives routine follow-up care from their doctors over three visits within six months. The other group takes part in a one-hour GEM consultation discussing geriatric assessment results and recommendations, attends survivorship health education sessions twice weekly for four weeks, and participates in a daily walking and resistance exercise program called EXCAP. Both survivors and their caregivers are involved in these activities. Throughout the study, participants complete patient-reported assessments on physical and cognitive function, objective tests like a 6-minute walk and cognitive exams, and questionnaires about satisfaction with care and coordination. Caregiver distress and quality of life are also measured. Follow-up continues for six months after the interventions to monitor outcomes and gather data on the effects of the GEM-S approach.
CONDITIONS
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Rochester
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | GEMS intervention | Usual care | Emerging practice: GA-informed survivorship |
|---|---|---|---|
| What it is | An intervention combining comprehensive geriatric assessment with survivorship education and exercise (GEMS) | Standard survivorship follow-up after curative-intent treatment | Survivorship care informed by geriatric assessment and tailored interventions |
| Role in trial | Investigational arm deploying GA and survivorship interventions | Comparator arm receiving usual care | An emerging model combining GA with survivorship care steps |
| Primary use | Supportive survivorship care integrating geriatric assessment, education, and exercise | Standard follow-up survivorship care | Tailoring survivorship care based on GA to optimize function and quality of life |
| How it is given or performed | Participants receive geriatric assessment, education sessions, exercise program and tailored consultation | Routine follow-up visits per standard protocols | Performing GA then providing tailored management and coaching |
| Evidence status | Efficacy under investigation in randomized trial (outcomes: physical and cognitive function up to 6 months) | No trial evidence; represents current standard follow-up practice | Randomized data show GA-informed management improves quality of life and reduces toxicity in older adults |
| Important risks | Risks not fully known; investigational supportive intervention | Not specific; includes usual follow-up without added risks | No direct harms reported; GA-guided management shows reduced treatment toxicity |
| Important limitations | Resource intensive; requires GA, education, and exercise implementation not yet standard in all practices | Does not include tailored geriatric assessment or structured survivorship education | Not yet established in survivorship settings; broader evidence mostly in treatment rather than post-treatment survivorship |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Participants must be 65 or older, have completed or be completing curative-intent cancer treatment within 6 months, and be able to attend study visits in person or remotely.
Duration - 4 to 6 months
Participants receive either routine survivorship follow-up care or participate in a geriatric consultation, survivorship health education sessions twice weekly for 4 weeks, and a daily exercise program.
3 visits over 6 months for routine care group; GEMS consultation and twice weekly 75-minute education sessions for 4 weeks plus daily exercise for intervention group
Duration - Up to 6 months after intervention
Participants are followed up to assess physical and cognitive function and other health outcomes at 6 months after completing the intervention.
Follow-up assessments at 6 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
S Yilmaz, M C Janelsins, M Flannery...
https://pubmed.ncbi.nlm.nih.gov/35292232/University of Rochester
Lead Sponsor
National Cancer Institute (NCI)
Collaborating Sponsor